Clinical
‘LARCs are suitable for women of all reproductive ages.’
Pharmacist-led research has found rates of hormonal LARC use almost doubled over the past decade, but uptake in Victoria and NSW was lower A new nationwide study has found that …
The shortage situation
The Therapeutic Goods Administration has recently made a number of updates to the database of medicine shortages and newly approved replacements Among the new listings or updates are: Fluoxetine capsules …
New treatment options approved
New medicine options approved after problems hit supply of depression treatments The Therapeutic Goods Administration has approved new overseas options after problems were revealed regarding the availability of a couple …
Compounding changes
TGA seeks feedback on proposed changes to compounded medicines guidelines The Therapeutic Goods Administration is seeking submissions from interested parties on its proposed changes to compounded medicine manufacturing practices and …
Opioid quantities studied
How many people were prescribed 10‐ or 20‐tablet pack sizes prior to PBAC-recommended changes? Research led by the Pharmacy Department at the Princess Alexandra Hospital in Brisbane has reviewed oxycodone …
Standing in the way of progress
Survey reveals how the pandemic has hampered the provision of vaccinations in Australian pharmacies COVID-19 pandemic has adversely affected the ability of pharmacists in Australia to provide vaccination services, new …
Stock issues strike again
TGA announces more medicine shortages are now impacting Australia The Therapeutic Goods Administration (TGA) is advising health professionals and consumers that there is an ongoing shortage of medicines containing olmesartan …
Unintentional overdose numbers climb
The number of Australians who die from unintentional drug overdose each year continues to rise, and is set to worsen due to COVID-19, a new report reveals. Released on International …
In short supply
TGA warns of a serious shortage of HRT patches, and their planned replacements, as well as some oral contraceptives Australia is facing a shortage of estradiol patches which will last …
Mixed decisions from scheduling committee
Ranitidine set to remain an S3 medicine, while TGA decides to downschedule migraine and acne treatments The Therapeutic Goods Administration (TGA) scheduling delegate has confirmed that the reflux treatment ranitidine …
Boost for minor ailment treatment
Running a national minor ailment scheme through community pharmacy is cost effective, and clinically effective, new research claims Researchers from the University of Technology Sydney conducted a randomised controlled trial …
Supply shutdown
Depression treatment no longer to be supplied in Australia Australian consumers and health professionals are being advised that phenelzine tablets will no longer being supplied, and stock is currently very …